Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selectiveglutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA

Piotr Popik, Ewa Kozela, Malgorzata Wróbel, Krystyna M. Wozniak, Barbara S. Slusher

Research output: Contribution to journalArticlepeer-review

Abstract

Inhibition of glutamate carboxypeptidase II (GCP II; NAALADase) produces a variety of effects on glutamatergic neurotransmission. The aim of this study was to investigate effects of GCP II inhibition with the selective inhibitor, 2-PMPA, on: (a) development of tolerance to the antinociceptive effects, (b) withdrawal, and (c) conditioned reward produced by morphine in C57/Blmice. The degree of tolerance was assessed using the tail-flick test before and after 6 days of twice daily (b.i.d.) administration of 2-PMPA and 10 mg/kg of morphine. Opioid withdrawalwas measured 3 days after twice daily morphine (30 or 10 mg/kg) administration, followed by naloxone challenge. Conditioned morphine reward was investigated using conditioned place preference with a single morphine dose (10 mg/kg). High doses of 2-PMPA inhibited the development of morphine tolerance (resembling the effect of 7.5 mg/kg of the NMDA receptor antagonist, memantine) while not affecting the severity of withdrawal. A high dose of 2-PMPA (100 mg/kg) also significantly potentiated morphine withdrawal, but inhibited both acquisition and expression of morphine-induced conditioned place preference. Memantine inhibited the intensity of morphine withdrawalaswellas acquisition and expression of morphine-induced conditioned place preference. In addition, 2-PMPA did not affect learning or memory retrievalin a simple two-trialtest, nor did it produce withdrawalsymptoms in morphine-dependent, placebo-challenged mice. Results suggest involvement of GCP II (NAALADase) in phenomena related to opioid addiction.

Original languageEnglish (US)
Pages (from-to)457-467
Number of pages11
JournalNeuropsychopharmacology
Volume28
Issue number3
DOIs
StatePublished - Mar 2003
Externally publishedYes

Keywords

  • Antinociception
  • Drug reward
  • Glutamate carboxypeptidase II
  • Memory
  • NMDA receptor antagonist
  • Opioid withdrawaland dependence
  • Tolerance

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selectiveglutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA'. Together they form a unique fingerprint.

Cite this